These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1576941)

  • 1. [Classical and new hemostasis risk factors in coronary disease].
    Willich SN
    Dtsch Med Wochenschr; 1992 May; 117(19):749-56. PubMed ID: 1576941
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes mellitus, vascular disease and thrombosis.
    Banga JD; Sixma JJ
    Clin Haematol; 1986 May; 15(2):465-92. PubMed ID: 3524933
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina.
    Lowe GD; Wood DA; Douglas JT; Riemersma RA; Macintyre CC; Takase T; Tuddenham EG; Forbes CD; Elton RA; Oliver MF
    Thromb Haemost; 1991 Apr; 65(4):339-43. PubMed ID: 2057913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic function in coronary artery disease (CAD).
    Gupta A; Sikka M; Madan N; Dwidedi S; Rusia U; Sharma S
    Indian J Pathol Microbiol; 1997 Apr; 40(2):133-7. PubMed ID: 9257498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemostatic anomalies and coronary risk].
    de Lorgeril M; Renaud S
    Rev Prat; 1992 Nov; 42(17):2136-40. PubMed ID: 1290035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which patients with coronary artery disease are most prone to develop a coronary artery event (presumably thrombosis)?
    Prentice CR
    Thromb Haemost; 1979 Feb; 41(1):63-72. PubMed ID: 384588
    [No Abstract]   [Full Text] [Related]  

  • 8. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations on the changes of the blood coagulation-fibrinolysis system as a risk factor of coronary heart disease. II. Changes of platelets, fibrinogen and antiplasmins in a group of 2,000 middle aged men (40-60 years) periodically followed up for three years.
    Papilian M; Niţă I
    Med Interne; 1975; 13(4):271-82. PubMed ID: 128813
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of several risk factors of atherosclerosis on rheologic properties of the blood].
    Murashko VV; Strutynskiĭ AV; Shabashova NI
    Ter Arkh; 1983; 55(12):19-22. PubMed ID: 6665709
    [No Abstract]   [Full Text] [Related]  

  • 11. The electrophoretic mobility of red cells and platelets and the plasma viscosity in coronary heart disease.
    Karppinen K
    Acta Med Scand Suppl; 1970; 506():1-42. PubMed ID: 5268180
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen as a risk factor for coronary heart disease.
    Montalescot G; Collet JP; Choussat R; Thomas D
    Eur Heart J; 1998 Jul; 19 Suppl H():H11-7. PubMed ID: 9717059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between white blood cell count and several risk factors for coronary heart disease in patients with systemic hypertension.
    Capuano V; Lamaida N; Mazzotta G; Scotto di Quacquaro G
    G Ital Cardiol; 1998 May; 28(5):530-5. PubMed ID: 9646068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic factors as triggers of cardiovascular events.
    Rosito GB; Tofler GH
    Cardiol Clin; 1996 May; 14(2):239-50. PubMed ID: 8724556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on the changes of the blood coagulation-fibrinolysis system as a risk factor for coronary heart disease. I. Prevalence of the changes in the blood coagulation-fibrinolysis system in a middle aged male population.
    Papilian M; Niţă I
    Med Interne; 1975; 13(2):95-103. PubMed ID: 128812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can modification of risk factors reduce coronary heart disease?
    Grundy SM
    Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery disease in women.
    Srinivasan KN; Satyamurthy I
    J Assoc Physicians India; 2002 Feb; 50():259-64. PubMed ID: 12038659
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol, platelets adhesiveness and fibrinolytic activity in ischaemic heart disease.
    Gupta KK
    J Assoc Physicians India; 1969 May; 17(5):323-31. PubMed ID: 5350177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.